MENU
PHAT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Phathom Pharmaceuticals (PHAT) Earnings Date & Reports

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company... Show more

A.I. Advisor
published Earnings

PHAT is expected to report earnings to rise 91.73% to -28 cents per share on March 03

Phathom Pharmaceuticals PHAT Stock Earnings Reports
Q4'25
Est.
$-0.29
Q3'25
Beat
by $0.32
Q2'25
Beat
by $0.12
Q1'25
Beat
by $0.04
Q4'24
Beat
by $0.42
The last earnings report on October 30 showed earnings per share of -15 cents, beating the estimate of -46 cents. With 976.39K shares outstanding, the current market capitalization sits at 1.06B.
View a ticker or compare two or three
PHAT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. PHAT showed earnings on October 30, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a biopharmaceutical company, which focuses on the development and commercialization of novel treatments for gastrointestinal diseases and disorders

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
100 Campus Drive
Phone
+1 877 742-8466
Employees
452
Web
https://www.phathompharma.com